Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home»Health & Beauty»Abraham Chan of PuraPharm Garners “Directors of the Year Awards 2016” from The Hong Kong Institute of Directors
    Health & Beauty

    Abraham Chan of PuraPharm Garners “Directors of the Year Awards 2016” from The Hong Kong Institute of Directors

    Marie JonesBy Marie JonesDecember 8, 2016Updated:December 8, 2016No Comments2 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    HONG KONG — PuraPharm Corporation Limited (“PuraPharm” or the “Group”, HKEX: 1498), a leading Hong Kong-based Chinese medicine company specialising in the research and development, production and sale of Concentrated Chinese Medicine Granules (“CCMG”) products under the “Nong’s” brand, announced that Mr. Abraham Chan, Founder, Chairman, Chief Executive Officer and Executive Director of PuraPharm, has been awarded “Directors of the Year Awards 2016” (Non-Hang Seng Indexes Constituents on SEHK – Executive Directors) by The Hong Kong Institute of Directors (“HKIoD”).

    The award acknowledges his outstanding performance in leading the Group in business development and also recognises his contribution in enhancing the efficiency of the Board and corporate governance.

    The Directors of the Year Awards 2016 is organized by HKIoD, aiming to recognize outstanding boards and directors and promote good corporate governance and professionalism among directors. This year’s main theme was “Corporate Sustainability – the Board’s Crucial Role.”

    The award winners are selected through a stringent set of procedures. As the first-of-the-kind in Asia, the Directors of the Year Awards has become an annual honors with strong influence in the society.

    Mr. Chan said, “We have been emphasizing corporate governance over the years and towards that end we have developed a comprehensive internal control and effective risk management system. I am very honoured to be receiving the award from HKIoD, which not only represents recognition of the Group’s excellent corporate governance, but also encourages our efforts in promoting the modernisation and internationalisation of Traditional Chinese Medicine (“TCM”). Of course, this award is also the result of the joint efforts and contributions of the Board and all employees. Apart from promoting the innovation and modernisation of TCM, PuraPharm also strives to achieve better performance through implementing best corporate governance practices. Looking ahead, we will continue to improve our corporate governance standard and remain steadfast in achieving the mission of promoting modernisation and internationalisation of TCM as well as enhancing awareness of the PuraPharm and Nong’s brands to capture the huge demand for TCM both within and outside the country.” – BusinessNewsAsia.com

    Chinese Medicine HKEX PuraPharm Corporation
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous Article“X-Spatial 4D Psychoacoustics” Technology Grand Launch & “Beyond Skyline” Movie Preview
    Next Article Statement By ISR Capital Limited Executive Chairman Chen Tong

    Related Posts

    LAC Spotlights Brain Health Amid Growing Stress Concerns in Singapore, Features Brain-Boosting Supplements to Combat Damage From Stressors

    August 8, 2024

    EC Healthcare Chairman Mr. Eddy Tang Further Increases Shareholding, Exhibiting Unwavering Assurance in the Future Development of the Group

    September 9, 2022

    EC Healthcare and AXA Jointly Establish the FIRST AXA Medical Centre

    September 8, 2022
    Add A Comment

    Comments are closed.

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.